Orth, M., B. Mayer, K. Rehm, U. Rothweiler, D. Heidmann, T. A. Holak and O. Stemmann: Shugoshin is a Mad1/Cdc20-like interactor of Mad2. In: EMBO Journal 30, 14, 2868-2880 (2011).
Rothweiler, U., A. Czarna, L. Weber, G. M. Popowicz, K. Brongel, K. Kowalska, M. Orth, O. Stemmann and T. A. Holak: NMR screening for lead compounds using tryptophan-mutated proteins. In: Journal of Medicinal Chemistry 51, 16, 5035-5042 (2008).
Rothweiler, U., A. Czarna, M. Krajewski, J. Ciombor, C. Kalinski, V. Khazak, G. Ross, N. Skobeleva, L. Weber and T. A. Holak: Isoquinolin-1-one inhibitors of the MDM2-p53 interaction. In: ChemMedChem 3, 7, 1118-1128 (2008).
Popowicz, G. M., A. Czarna, U. Rothweiler, A. Szwagierczak, M. Krajewski, L. Weber and T. A. Holak: Molecular basis for the inhibition of p53 by Mdmx. In: Cell Cycle 6, 19, 2386-2392 (2007).
Krajewski, M., U. Rothweiler, L. D'Silva, S. Majumdar, C. Klein and T. A. Holak: An NMR-Based antagonist induced dissociation assay for targeting the ligand-protein and protein-protein interactions in competition binding experiments. In: Journal of Medicinal Chemistry 50, 18, 4382-4387 (2007).
Krajewski, M., P. Ozdowy, L. D'Silva, U. Rothweiler and T. A. Holak: NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro. In: Nature Medicine 11, 11, 1135-1136 (2005).
D'Silva, L., P. Ozdowy, M. Krajewski, U. Rothweiler, M. Singh and T. A. Holak: Monitoring the effects of antagonists on protein-protein interactions with NMR spectroscopy. In: Journal of the American Chemical Society 127, 38, 13220-13226 (2005).
The Max Planck Society does not take any responsibility for the content of this export.